Σύγκριση μεθόδων

	AIMS: Κλίμακα Αξιολόγησης Ακούσιων Κινήσεων	NIHSS: Κλίμακα Εγκεφαλικού Επεισοδίου των Εθνικών Ινστιτούτων Υγείας
Πεδίο	Νευρολογία	Νευρολογία
Οικογένεια	Process / pipeline	Process / pipeline
Έτος προέλευσης	1976	1989
Δημιουργός	National Institute of Mental Health	Thomas Brott and NIH Stroke Study Group
Τύπος	Clinician-rated observation	Clinician-rated
Θεμελιώδης πηγή	National Institute of Mental Health (1976). Abnormal Involuntary Movement Scale (AIMS). In: Rockland, L. H., Schooler, N. R., & Levine, J. (Eds.), Drug Treatment of Mental Disorders. New York: Raven Press.	Brott, T., Adams, H. P., Olinger, C. P., et al. (1989). Measurements of acute cerebral infarction: A clinical examination scale. Stroke, 20(7), 864-870.
Εναλλακτικές ονομασίες	AIMS	NIH Stroke Scale
Συναφείς	3	5
Σύνοψη	The Abnormal Involuntary Movement Scale (AIMS) is the standard clinical rating scale for assessing tardive dyskinesia, a iatrogenic movement disorder resulting from chronic antipsychotic medication exposure. Developed by the National Institute of Mental Health in 1976, the 12-item scale systematically measures involuntary movements across facial, oral, limb, and trunk regions. The AIMS is mandatory screening tool for patients on long-term antipsychotic therapy and essential for monitoring antipsychotic-associated movement complications.	The NIHSS is the standard acute stroke severity assessment tool used in emergency departments, stroke centers, and clinical trials worldwide. Developed by the NIH Stroke Study Group in 1989, the 15-item scale provides rapid, reproducible quantification of acute neurological deficit from ischemic or hemorrhagic stroke. NIHSS scores inform thrombolytic and thrombectomy eligibility, predict outcomes, and serve as primary endpoint in stroke intervention trials.